Heart Disease

Victorion-2 Prevent

To evaluate the impact of a new medication on participants who have established cardiovascular disease and who have had a major adverse cardiovascular event.

Trial overview

Topic

Cardiovascular Disease

Eligibility criteria

To be considered for the study you must meet the following criteria: 

  • Aged ≥40 years or older
  • Fasting LDL-C ≥1.8 mmol/L
  • Established Cardiovascular Disease defined as any of these 3 conditions:
    • Stroke
    • Myocardial Infarction
    • Peripheral Artery Disease

Study details

To evaluate the impact of a new medication on participants who have established cardiovascular disease and who have had a major adverse cardiovascular event.

Your participation in this study would be for approximately 6 years.  You will be required to attend the clinic for an initial screening visit where a small blood sample as well as a urine sample will be collected along with the completion of a physical exam.

Following the screening visit, eligible participants are required to attend in-clinic visits on Day 1, Month 3, and then every 6 months thereafter for the duration of the study. During these in-clinic visits, the study drug will be administrated subcutaneous under the skin. You will also have blood samples taken at these visits along with questions asked regarding your current health status.

There are no additional costs associated with participating, nor will you be paid. All medication, tests and medical care required as part of the study will be provided to you free of charge.

Further information

Please click here for more information.

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.